Recognizing Kawasaki disease

Paediatrics and Child Health

Volumn 6, Issue 9, 2001, Pages 638-643

  Lang, Bianca ^a  

^a IWK HEALTH CENTRE   (Canada)

Author keywords

Diagnosis; Kawasaki disease; Treatment; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CHICKENPOX VACCINE; CORTICOSTEROID; DIPYRIDAMOLE; IMMUNOGLOBULIN; INFLUENZA VACCINE; METHYLPREDNISOLONE;

AGE; CASE REPORT; CHILDHOOD DISEASE; CORONARY ARTERY ANEURYSM; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; FEVER; HUMAN; INCIDENCE; INFANT; JAPAN; LABORATORY TEST; LONG TERM CARE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SEX DIFFERENCE; THROMBOSIS; VASCULITIS;

EID: 0035718963     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/6.9.638     Document Type: Review

References (38)

1. Recognition and management of Kawasaki disease
2. Nationwide survey of Kawasaki disease and acute rheumatic fever
3. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan
4. Kawasaki syndrome: Clinical features. Pathophysiology, etiology and therapy
5. Diagnosis and therapy of Kawasaki disease in children
6. Kawasaki disease and perineal rash
7. Kawasaki syndrome
8. Kawasaki syndrome: Report of four cases with acute gallbladder hydrops
9. Neurological complications in Kawasaki disease
10. Anterior uveitis associated with Kawasaki syndrome
11. Evaluation method for the degree of seriousness in Kawasaki disease
12. Kawasaki disease: Review of risk factors for coronary aneurysms
13. A predictive instrument for coronary artery aneruysms in Kawasaki disease
14. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age
15. Kawasaki disease in infants less than one year of age
16. Atypical and complicated Kawasaki disease in infants. Do we need criteria?
17. Kawasaki disease in older children and adolescents
18. Atypical Kawasaki disease: Analysis of clinical presentation and diagnostic clues
19. Incidence and clinical features of incomplete Kawasaki disease
20. The prevention of coronary artery aneurysm in Kawasaki disease: A meta-analysis on the efficacy of aspirin and immunoglobulin treatment
21. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent of gamma globulin dose but independent of salicylate dose
22. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome
23. Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities
24. Gamma-globulin retreatment in Kawasaki disease
25. Kawasaki disease: Effect of treatment on coronary artery involvement
26. Corticosteroids in the treatment of the acute phase of Kawasaki disease
27. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids
28. Guidelines for long-term management of patients with Kawasaki disease. Report from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young. American Heart Association
29. Kawasaki disease. Epidemiology, late prognosis, and therapy
30. Measles
31. Management of Kawasaki syndrome: A consensus statement prepared by North American participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1998
32. Long-term consequences of Kawasaki disease: A 10- to 21-year follow-up study of 594 patients
33. Sequelae of Kawasaki disease in adolescents and young adults
34. Pathological study of postcoronary arteritis in adolescents and young adults: With reference to the relationship between sequelae of Kawasaki disease and atherosclerosis
35. Long term consequences of regressed coronary aneurysms after Kawasaki disease: Vascular wall morphology and function
36. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound
37. Impaired endothelial cell function in epicardial coronary arteries after Kawasaki disease
38. Endothelial dysfunction late after Kawasaki disease